NewsRoom Articles - Page 57 of 207

FridayAug 25, 2023 9:45 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to Unlock Potential Treatments and Cures for Serious Infectious Diseases and Cancer

Renovaro’s current product development pipeline includes a variety of treatment candidates spanning cancer, HIV, and HBV Renovaro’s Pre-Investigational New Drug (pre-IND) submission included a human study plan covering pancreatic cancer, as well as other cancers that are difficult to treat The company recently entered into an LOI with GEDi Cube that could enhance the efficacy of upcoming trials and speed up delivery results As an advanced, pre-clinical biotechnology company specializing in cell, gene, and immunotherapy, Renovaro BioSciences (NASDAQ: RENB), formerly Enochian BioSciences Inc., aims to unlock potentially long-term or life-long cancer remission in some of the deadliest cancers and to…

ThursdayAug 24, 2023 2:05 pm

Australia Brings New HIV Infections to Near Zero

Central districts in the Australian city of Sydney may soon break HIV infection records by becoming the first places in the world to achieve the United Nation’s target for eliminating HIV transmission. Researchers note that several Sydney districts are close to hitting UN targets for HIV infection, putting the country on track to achieving a 90% drop in new HIV cases by 2030. Several decades ago Sydney was in the grip of an HIV pandemic that took thousands of gay men's lives between the 1980s and 1990s. Between 2010–2022, however, new cases among gay men in the city went down…

WednesdayAug 23, 2023 2:04 pm

Canadian Researchers Design Powerful Imaging Tech to Boost Cancer Fight

Canadian researchers have developed a powerful imaging technique that would aid physicians in their fight against cancer. The team from the School of Biomedical Engineering at Dalhousie University in Canada has designed a high-resolution endoscopic surgical and imaging probe, the very first in the world capable of allowing surgeons to see brain tumors in 10 times more resolution than traditional imaging technologies such as CT and MRI scans. Brain cancers are among the most debilitating types of cancer, affecting tens of thousands of Americans each year, and are forecast to take close to 20,000 lives in 2023. Tumors of the…

WednesdayAug 23, 2023 9:45 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

For the quarter ended June 30, 2023, RVLP reported net sales of $8.3 million and operating expenses of $14.4 million, down 2% and 32%, respectively, compared to the prior year period; this strategy is designed to extend cash runway for future business development and changes in the company’s marketing mix The company’s marketing partner, Santen, has commenced the required registrational trial for UPNEEQ(R) in Japan and plans to begin the same in China in 2023 UPNEEQ(R) has strong U.S. intellectual property protection, with patents extending to 2039 RVL Pharmaceuticals launched its prescription ecommerce platform, Elevate, in July 2023, allowing providers…

WednesdayAug 23, 2023 9:00 am

Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer

Combination of advanced AI machine learning technology and proven immunotherapy technology seen as “future of medicine” Demonstrated success that both companies have shown with their innovative developments is expected to expand synergistically Potential applications against variety of cancers The announcement of a binding and exclusive letter of intent to merge, between two of the most innovative companies in their respective fields, is seen as representing a potentially transformative step in the fight against cancer. Considering Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy, that has already demonstrated significant results with its technology against pancreatic…

TuesdayAug 22, 2023 4:04 pm

How Allergy Sufferers Can Benefit from Immunotherapy

The Centers for Disease Control and Prevention (CDC) estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy. Common allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and immunotherapy for severe cases. Immunotherapy is the preferred treatment option for people with allergies that…

MondayAug 21, 2023 1:33 pm

Insider Intelligence Data Projects Health, Personal Care, Beauty eCommerce to Grow Fastest

Recent analysis by market research firm Insider Intelligence has revealed that the fastest-growing sales category in e-commerce is foods and drinks. The market researcher predicts that the food and drink e-commerce segment will expand by 20% in 2023 to reach $99.70 billion in sales and account for 8.8% of total e-commerce sales in the United States. According to Insider Intelligence, the food and drinks segment will comprise up to 10% of America’s total e-commerce sales by the year 2026. Insider Intelligence forecasting analyst Whitney Birdsall explains that inflation is partly responsible for the growth of the food and drinks sales…

FridayAug 18, 2023 1:01 pm

Analyzing Link Between Hormonal Contraceptives, Autoimmunity

Autoimmune diseases occur when the immune system mistakes healthy tissues for harmful bacteria, viruses, or infections and starts to attack the body. Referred to as autoimmunity, this phenomenon causes significant damage to healthy tissues and results in more than 100 autoimmune conditions. Data has consistently shown that women are four times more likely to develop autoimmune diseases compared to men. While some researchers have posited that the X chromosome may increase the risk of autoimmunity in women because it is more likely to cause a higher number of mutations, we still don’t know why autoimmune diseases affect women at much…

FridayAug 18, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Advances NanoAb Therapy as IL-17 Drug Candidate for Psoriasis Treatment

Similar business model but different antibody therapies for psoriasis treatment, BiondVax uses NanoAbs while Apogee Therapeutics, Inc. uses conventional mAbs BiondVax NanoAbs provide superior benefits not seen in mAb therapies, including new routes of administration, higher affinity, better binding, and a higher level of stability at room temperature Apogee recently went public at $500 million pre-money, raising $300 million in an upsized deal, and has a $1 billion market cap – should be an eye-opener to BiondVax investors who recognize benefits of NanoAbs over mAb development The global psoriasis treatment market was valued at $26.13 billion in 2022 and is…

ThursdayAug 17, 2023 1:44 pm

Researchers Develop Novel Way to Detect Pediatric Brain-Cancer Mutations

Uppsala University researchers have created a novel method for detecting brain-cancer mutations in children, granting scientists an unprecedented glimpse into the inner workings of pediatric brain tumors. The novel technique allowed the researchers to determine that the mutations they saw changed how tumor cells interact with cancer drugs, potentially opening the door for the development of better means of diagnosing pediatric brain cancer and building personalized treatment plans. Medulloblastoma, a type of brain tumor that originates in the cerebellum, is the most common type of brain cancer in children. It has a 70% survival rate after five years if treatment…